Nephros, Inc. (NEPH)
NASDAQ: NEPH · IEX Real-Time Price · USD
2.190
-0.020 (-0.90%)
At close: Jul 26, 2024, 3:59 PM
2.250
+0.060 (2.74%)
After-hours: Jul 26, 2024, 6:25 PM EDT
Nephros Market Cap
Nephros has a market cap or net worth of $23.09 million as of July 26, 2024. Its market cap has increased by 53.94% in one year.
Market Cap
23.09M
Enterprise Value
21.38M
1-Year Change
53.94%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $23.09M, a decrease of -57.32%. That is a compound annual growth rate of -15.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 23.30M | -35.81% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 25.10M |
| Trinity Biotech | 25.09M |
| BioVie | 24.91M |
| Unity Biotechnology | 24.34M |
| Biora Therapeutics | 23.48M |
| CytoMed Therapeutics | 23.20M |
| Ekso Bionics Holdings | 23.17M |
| Cocrystal Pharma | 22.99M |